Patents by Inventor Dennis Beringer

Dennis Beringer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for identifying ?T-cell (or ?T-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective response
    Patent number: 11166984
    Abstract: The present invention relates to a method for identifying ?T-cell (or ?T-cell) receptors chains or parts thereof that mediate an anti-tumor or anti-infection response by identifying amino acid sequences comprising ?T-cells (or ?T-cell) receptors chains or parts thereof that are shared between different donors.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: November 9, 2021
    Assignees: UMC UTRECHT HOLDING B.V., Gadeta B.V., Albert-Ludwigs-Universität Freiburg
    Inventors: Jürgen Herbert Ernst Kuball, Anke Janssen, Dennis Beringer, Paul Fisch, Jose Alberto Villacorta Hidalgo
  • Novel method for identifying deltaT-cell (or gammaT-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective response
    Publication number: 20210177901
    Abstract: The present invention relates to a method for identifying ?T-cell (or ?T-cell) receptors chains or parts thereof that mediate an anti-tumor or anti-infection response by identifying amino acid sequences comprising ?T-cells (or ?T-cell) receptors chains or parts thereof that are shared between different donors.
    Type: Application
    Filed: December 17, 2020
    Publication date: June 17, 2021
    Applicants: UMC Utrecht Holding B.V., Gadeta B.V., Albert-Ludwigs-Universität Freiburg
    Inventors: Jürgen Herbert Ernst Kuball, Anke Janssen, Dennis Beringer, Paul Fisch, Jose Alberto Villacorta Hidalgo
  • COMPOSITIONS AND METHODS FOR CELL TARGETING THERAPIES
    Publication number: 20200368278
    Abstract: Described herein are compositions and methods of treatment for identifying and clearing cell types expressing particular cell surface markers. In one embodiment, the composition comprises a polypeptide construct that selectively binds a J-configuration of CD277 on a target cell, wherein said polypeptide construct is expressed in an engineered cell.
    Type: Application
    Filed: May 18, 2018
    Publication date: November 26, 2020
    Inventors: Jürgen Herbert Ernst KUBALL, Zsolt SEBESTYEN, Dennis BERINGER, Anna VYBOROVA
  • Novel Method for Identifying DeltaT-Cell (or GammaT-Cell) Receptor Chains or Parts Thereof that Mediate an Anti-Tumour or an Anti-Infective Response
    Publication number: 20190209613
    Abstract: The present invention relates to a method for identifying ?T-cell (or ?T-cell) receptors chains or parts thereof that mediate an anti-tumor or anti-infection response by identifying amino acid sequences comprising ?T-cells (or ?T-cell) receptors chains or parts thereof that are shared between different donors.
    Type: Application
    Filed: December 10, 2018
    Publication date: July 11, 2019
    Inventors: Jürgen Herbert Ernst Kuball, Anke Janssen, Dennis Beringer, Paul Fisch, Jose Alberto Villacorta Hidalgo